Richard Yu, CEO of Huawei's consumer business, said Huawei's own operating system for smartphones and laptops could be ready for use in China by fall this year.Technologyread more
British Prime Minister Theresa May could announce her resignation in the next few days, according to U.K. media reports, as she faces increasing pressure from members of her...Europe Politicsread more
Shares of Chinese telecommunications heavyweight Huawei's suppliers took a hit on Thursday amid the ongoing fallout surrounding the Chinese telecommunications giant.Asia Marketsread more
Lawmakers, lobbyists and CEOs in the U.S. are looking to trying to pick out the best parts of the EU's privacy law called GDPR – and ditch what they see as the worst.Technologyread more
After holding parliamentary elections over seven phases, India started counting the votes on Thursday — and Prime Minister Narendra Modi's Bharatiya Janata Party-led coalition...Electionsread more
The embattled German lender saw its share price hit a record low Monday, down nearly 5% since the start of the year.Banksread more
Among the many ways Trump has shattered White House norms, his impulsive public communications rank among the most consequential. By inspiring investors or spooking them, his...Politicsread more
Political experts believe the vote could give more insight into national politics in each member state, rather than on the future of the EU itself.Europe Politicsread more
A federal judge in New York City on Wednesday said Deutsche Bank and Capital One can turn over financial documents related to President Donald Trump and his businesses in...Politicsread more
China accounted for 40% to 60% of the global increase in trichlorofluoromethane, or CFC-11, emissions between 2014 and 2017, a study found.Scienceread more
CNEX, backed by Microsoft and Dell, filed new allegations in a Texas suit accusing China's Huawei and an executive of trade secrets theft.Technologyread more
It's time to re-examine the role of pharmacy benefit managers and understand how their financial arrangements work, Health and Human Services Secretary Alex Azar said Friday.
President Donald Trump is to unveil on Friday his plan to lower prescription drug prices. Pharmacy benefit managers, which negotiate with drug manufacturers, have been a common target from industry and lately even administration officials.
Drugmakers accuse the PBMs of profiting off higher list prices because they can negotiate bigger discounts. PBMs say it's manufacturers' fault for setting the high prices in the first place.
Azar, in an interview with CNBC's "Squawk Box, " said everybody's gaining something from higher list prices — except patients and taxpayers.
"Everybody is wetting their beak on a percent of a higher list price, and we've got to change those dynamics," said Azar, a former executive at pharmaceutical giant Eli Lilly.
"We have to fundamentally examine and re-examine the role of pharmacy benefit managers, which serve a very important function in this system of negotiating, but how do the financial arrangements work? Who are they collecting money from? And how are things structured in terms of that list price to net price dynamic? Because those incentives are driving it," Azar said.
A summary of the blueprint, dubbed "American Patients First," mentions pharmacy benefit managers but does not include any proposals directly aimed at them. The administration is slated to publish the entire plan Friday in conjunction with Trump's speech.